MikeTrendsTrends right now
AI: reposAPI

search

Nektar Therapeutics

Trends

  1. 1
    Jury Orders Eli Lilly to Pay Nektar $90 Million▼A Jury Awarded Nektar $90 Million From Eli Lilly. Here’s Why the Stock Barely Moved✉newsBusinessMarkets15 h ago

    A jury awarded Nektar Therapeutics $90 million in damages from Eli Lilly, yet Nektar's stock barely moved after the decision. Commentators attribute the muted reaction to the award being small relative to the stakes and uncertainty over whether the verdict will survive appeals. Investors appear to have largely priced in the outcome, with attention staying on Nektar's drug pipeline rather than litigation.